Financial Data and Key Metrics Changes - The group's revenue increased by 81.9% year over year to approximately $519 million [43] - Adjusted profit from continuing operations grew significantly to about $178 million [43] - The net loss narrowed to approximately $24.5 million, largely affected by Legend Biotech's performance [43] Business Line Data and Key Metrics Changes - GenScript Life Science Group's revenue grew by 11.3% to about $248 million [45] - ProBio's revenue surged by 511% to around $402 million [43] - Bestzyme's revenue increased by 8.4% to $28.3 million [43] Market Data and Key Metrics Changes - Revenue from industry customers, particularly pharma, increased due to the development of more M&D companies [45] - Revenue from the Americas and European markets grew, thanks to the successful execution of the global market strategy [48] Company Strategy and Development Direction - The company is focused on expanding market penetration for protein, mRNA, and cell and gene engineering [55] - Investments are being made in automation, capacity expansion, and digital transformation to enhance operational efficiency [55] - The company aims to leverage its global footprint to provide speed, reliability, and consistent delivery to customers [78] Management's Comments on Operating Environment and Future Outlook - Management noted that the geopolitical environment remains complex but the company delivered rapid growth [6] - There is confidence in achieving margin improvement through strategic investments and operational efficiencies [94] - The company anticipates a stronger growth trajectory in the second half of the year across all segments [45] Other Important Information - The company achieved significant ESG milestones, including an upgrade to AA in MSCI ESG ratings and inclusion in the FTSE4Good index [10] - The cash position stood at $970 million, supporting global expansion and R&D efforts [9] Q&A Session Summary Question: ProBio's fee for service and COGS trends - Management clarified that excluding the Lenovo collaboration impact, fee for service business achieved double-digit growth [62] Question: Bestzyme's product breakdown and growth expectations - Management indicated that new product launches and expanded sales personnel in key markets are expected to drive growth in the second half [65] Question: Future milestone payments from Lenovo collaboration - Management expects to recognize a milestone payment of $300 million in the second half, with further payments dependent on clinical trial progress [76] Question: Global expansion and long-term revenue contribution - Management emphasized the importance of a robust global footprint for flexibility and resilience, aiming for sustainable growth [78] Question: Tariff impact on profits - Management reported that tariffs had a low impact on profits, under $4 million, due to the nature of the business [85] Question: ProBio's order trends and backlog - Management noted steady growth in orders and a clear recovery in antibody and protein R&D, with a focus on active backlog management [88]

Financial Data and Key Metrics Changes - The group's revenue increased by 81.9% year over year to approximately $519 million [44] - Adjusted profit from continuing operations grew significantly to about $178 million [44] - The net loss narrowed to about $24.5 million, largely affected by Legend Biotech's performance [44] Business Line Data and Key Metrics Changes - GenScript Life Science Group's revenue grew by 11.3% to about $248 million [46] - ProBio's revenue surged by 511% to around $402 million [44] - Bestime's revenue increased by 8.4% to $28.3 million [52] Market Data and Key Metrics Changes - Revenue from the Americas and European markets grew due to successful execution of global market strategies [49] - The proportion of revenue from international customers for Bestime grew to 23% [52] Company Strategy and Development Direction - The company is focused on expanding market penetration for protein, mRNA, and cell and gene engineering [57] - There is a commitment to advancing CDMO platforms and exploring out-licensing opportunities to maximize R&D benefits [58] - The company is investing in automation and digital transformation to enhance operational efficiency [59] Management's Comments on Operating Environment and Future Outlook - Management anticipates stronger growth in the second half of the year, driven by increased demand and strategic investments [46][55] - The company is confident in achieving margin improvement through enhanced automation and capacity expansion [100] Other Important Information - The company achieved significant ESG milestones, including a silver medal from EcoVadis and an AA rating from MSCI [12] - The cash position stood at $970 million, supporting global expansion and R&D progress [10] Q&A Session Summary Question: ProBio's fee for service revenue and cost of goods sold - Management clarified that excluding the impact of the Lenovo case, fee for service business achieved double-digit growth, and costs were impacted by capacity ramp-up [63][64] Question: Bestime's product breakdown and growth expectations - Management noted that new enzyme products are expected to drive revenue growth in the second half, with confidence in the performance of innovative enzymes [66] Question: Future milestone payments from Lenovo - Management indicated that a milestone payment of $300 million is expected in the second half, with further payments dependent on clinical trial progress [80][82] Question: Global expansion and long-term revenue contribution - Management emphasized the importance of a robust global footprint to ensure speed and reliability for customers, which will support sustainable growth [83][84] Question: Impact of tariffs on profit - Management reported that tariffs had a low impact on profits, less than $4 million, due to the nature of the business and global capacity [90] Question: ProBio's order trends and backlog - Management observed steady growth in orders, with a clear recovery in antibody and protein R&D, and noted that backlog information is no longer disclosed [93][95] Question: Key drivers for Life Science guidance upgrade - Management attributed the guidance upgrade to strong demand momentum and deeper market penetration, while also addressing temporary gross margin impacts [98][100] Question: Future blockbuster products from Bestime - Management confirmed that new products have entered mass production and are expected to drive significant process optimization and cost reduction for clients [109] Question: AI-driven protein and canary business growth - Management highlighted the integration of advanced technology in AI-driven engineering, which plays a critical role in enhancing customer offerings [112]

Financial Data and Key Metrics Changes - The company reported adjusted revenues of USD 32.1 million, adjusted EBITDA of USD 21.6 million, and adjusted net income of USD 17.4 million for Q2 2025 [4][5]. - Average AUM decreased to USD 748 million from USD 780 million in Q1 due to negative cryptocurrency price movements [16]. - Q2 IFRS revenue was USD 13.4 million, leading to a cumulative revenue of USD 57.1 million for the first half of the year, which was below the guidance of USD 62.5 million, resulting in a shortfall of USD 5.5 million or 8.7% [17]. Business Line Data and Key Metrics Changes - Valor, the largest business unit, reported net inflows of USD 77.4 million year-to-date, with AUM ending Q2 at USD 772.8 million and reaching USD 947 million by July 31 [5][6]. - Stoneman Digital generated USD 1.9 million in revenue for Q2, focusing on market making and liquidity for stablecoins [7]. - DeFi Alpha executed a trade in May with returns of USD 17.3 million, maintaining a zero-loss track record since inception [8]. Market Data and Key Metrics Changes - The company experienced strong cash inflows into ETPs, with positive Q2 inflows of USD 27 million [16]. - The effective realized staking income was 3.6% on the average AUM of USD 748 million, with staking revenue declining due to lower on-chain activity and average prices of key assets [19]. - The effective management fee yield during Q2 was 1.1%, down from 1.3% in Q1, primarily due to the performance of Bitcoin and Ethereum [20]. Company Strategy and Development Direction - The company aims to expand its product offerings, targeting 100 listed products by year-end and entering new markets in Africa, Asia, and the Middle East [12][14]. - The strategic focus includes building a comprehensive portfolio of digital asset ETPs and developing hybrid products that combine digital and traditional assets [56][57]. - The company is also exploring opportunities in the DeFi advisory space, leveraging its expertise to assist public companies in managing digital asset treasury strategies [66]. Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth potential, stating that the company is still early in its growth story and that the flywheel effect of its subsidiaries is reinforcing each other [5][14]. - The company raised its 2025 annualized operating revenue guidance to USD 218 million, citing a stronger market position and higher expected yields from its asset composition [11][34]. - Management acknowledged the challenges posed by market conditions in Q2 but indicated a positive outlook for the second half of the year, driven by improved asset performance [24][76]. Other Important Information - The company ended Q2 with USD 26.4 million in cash and USD 26 million in digital assets, maintaining a strong balance sheet [11][21]. - The company is in the process of renewing its share buyback program, having repurchased 675,900 shares during Q2 [22]. - An investigation into share discrepancies was initiated at the request of shareholders, with initial reports raising flags about unpaired shares on specific trading days [80][81]. Q&A Session Summary Question: Can you help us bridge the guidance of USD 218 million? - The guidance was adjusted due to a change in portfolio composition, which improved the monetization rate for the rest of the year [34][35]. Question: What is the six-month USD revenue number? - The revenue for the first six months is estimated to be around USD 12-13 million in staking and USD 4.5 million in management fees, with the rest coming from trading activity [36][37]. Question: What are the roadblocks to expanding into Africa, Asia, and the Middle East? - The expansion is more about finalizing regulatory details rather than facing significant roadblocks, with strong demand for products in these regions [48][50]. Question: Can you provide more color on the DeFi Alpha business? - Management is optimistic about executing trades in the pipeline, with a target of completing around 65% of them this year [75][78]. Question: What is the company's stance on the Canadian listing and potential redomiciling to the US? - The company is exploring options regarding its Canadian listing but faces potential tax implications if it were to redomicile to the US [84][88].

Financial Data and Key Metrics Changes - Sadat Group reported its fifth consecutive quarter of positive net income and positive EBITDA in Q2 2025, marking a significant turnaround from previous losses as a restaurant-only concept [6][7] - Revenue for Sadat Agri Foods in Q2 2025 was $114.4 million, a decrease of $58.9 million or 34% compared to Q2 2024, primarily due to selective trading with more favorable margins [21] - Gross profit improved to 4.4% in Q2 2025 from 3.3% in Q2 2024, an increase of 100 basis points attributed to higher margin trades [21] - Net income attributable to Sadat Group was $400,000 in Q2 2025, with EBITDA reported at CAD 1.7 million [21] - The company had a cash balance of $400,000 and a working capital surplus of $24.2 million [22] Business Line Data and Key Metrics Changes - The company completed 26 transactions representing over 200,000 metric tons of product shipped in Q2 across seven different countries [21] - SG&A expenses increased to £2.8 million, up £1.1 million from the previous year, mainly due to reclassifying some expenses [22] Market Data and Key Metrics Changes - The company announced a strategic investment in a carbon project in Indonesia, assigning approximately $13.4 million of accounts receivable to acquire a 37.5% equity stake in a local entity focused on carbon credits [23] Company Strategy and Development Direction - Sadat Group's strategy focuses on five core pillars: geographic and vertical expansion, operational efficiency, margin improvement, technological integration, and leadership excellence [12][13] - The company aims to modernize its operations through AI and data-driven technologies, enhancing decision-making capabilities across the trading lifecycle [11][12] - Sadat Group is transitioning from a restaurant-focused business to a diversified technology-enabled global agribusiness [12][25] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges of transitioning from a restaurant company to a global agriculture player, emphasizing the importance of skilled personnel in finance and technology [30] - The company is committed to divesting its restaurant holdings to focus on core agricultural operations and drive long-term shareholder value [31] Other Important Information - The company raised $2.5 million due to delays in collecting receivables and closing the sale of restaurants, indicating a non-toxic equity deal without warrants [28] - Management expressed confidence in the company's ability to navigate tariff concerns, noting that only a small percentage of trades are conducted with the United States [29] Q&A Session Summary Question: What is the status on the sale of the restaurants? - Management expressed dissatisfaction with the slow progress but confirmed they are in the final stages of negotiations with strong candidates for acquisition [26][27] Question: Why did the company recently raise $2.5 million and what are the proceeds being used for? - The capital was raised due to delays in collecting receivables and closing the sale of restaurants, structured as a straight equity deal [28] Question: How do tariffs affect Sadat Group? - Management indicated that only a small percentage of trades are with the U.S., allowing flexibility to avoid tariffs by moving transactions globally [29] Question: Why have there been so many changes in the board and management? - The changes are part of the strategic pivot from a restaurant company to an international player in the food supply chain, requiring specific skill sets [30]

Financial Data and Key Metrics Changes - Sales for Q2 2025 increased by 8% compared to Q2 2024, reaching $11,370,000 compared to $10,530,000 [21] - Q2 2025 recorded a profit of $2,030,000 or $0.16 per share, compared to a profit of $1,290,000 or $0.10 per share in Q2 2024 [22] - The company recorded unusual R&D revenue of $2,500,000 in Q2 2025, which significantly contributed to the profit [22][34] Business Line Data and Key Metrics Changes - The NanoChem division (NCS) represents approximately 70% of the company's revenue, focusing on biodegradable polymers and nitrogen conservation products [4] - The E&P division is expected to continue growth in 2025, with early signs of improvement in Q3 [14] - The food division is anticipated to have lower margins initially due to tariff and inflation protection clauses in new contracts [13] Market Data and Key Metrics Changes - Agricultural products in the U.S. are under pressure, with crop prices not increasing at the rate of inflation, leading to uncertainty for growers [15] - Tariffs on imports of raw materials from China range from 30% to 68%, impacting costs and pricing strategies [16] - The company is transitioning production to Panama to mitigate tariff impacts and improve shipping efficiency [19] Company Strategy and Development Direction - The company is focusing on expanding its food grade operations and has secured a five-year contract with a minimum revenue of $6,500,000 per year [10] - Plans to develop a new facility in Panama to produce products for international customers, reducing exposure to U.S. tariffs [19] - The company aims to optimize food grade production in the U.S. while expanding its international sales capabilities [20] Management Comments on Operating Environment and Future Outlook - Management expects continued weakness in agriculture sales due to external pressures, but anticipates a return to growth in the second half of 2025 [15] - The company is confident in executing its plans without the need for equity financing, relying on existing capital and cash flow [26] - Management believes that the recent contracts and operational improvements will lead to increased revenue and profitability in the coming quarters [12] Other Important Information - The company has substantial cash on hand and access to unused lines of credit, ensuring adequate working capital for operations [8][26] - The transition to the Panama facility is expected to begin production in Q3 2025, with all equipment already on site [18] Q&A Session Summary Question: What is the business magic behind getting new food contracts? - The company emphasizes its role as a solution provider, focusing on R&D to meet customer needs [28][29] Question: How was the R&D contract treated in financials? - The R&D revenue was classified as a second line in revenue, indicating its significance to the quarter's performance [33][34] Question: What are the expected margins for the food contracts? - The company anticipates net margins before tax in the range of 22% to 25%, with a 31% income tax rate applicable [35] Question: How is the E&P division performing? - The E&P division is showing steady growth, while agriculture remains uncertain due to external factors [46][47] Question: Will the wine product move to Panama? - The wine product will remain in Illinois for now, as the Panama facility is not yet food grade certified [50]

Financial Data and Key Metrics Changes - The company reported a return on equity (ROE) of 20.7% for Q2 2025, reflecting strong operating performance and disciplined risk management [13][52] - Net interest income increased by 4.2%, supported by a contraction in interest expenses and an improved funding mix [25][50] - The efficiency ratio stood at 44.2%, indicating effective cost control and scalability of digital investments [15][51] Business Line Data and Key Metrics Changes - Universal banking and insurance and pensions posted strong results, while microfinance continued to recover [13] - Fee income increased by 8.2%, driven by transactional activity at JAPI and BCP [26] - The innovation portfolio contributed 6.2% of risk-adjusted revenues, on track towards a 10% target for 2026 [13] Market Data and Key Metrics Changes - Peru's GDP is expected to grow by 3.2% in 2025, with domestic demand growing around 4.5% [8][29] - Inflation in Peru has remained below 2% for seven consecutive months, supporting recovery in private consumption [31][29] - The terms of trade have reached their highest level in 75 years, driven by elevated prices of gold, silver, and copper [29] Company Strategy and Development Direction - The company is focused on building a more agile, balanced, and forward-looking platform, emphasizing digital infrastructure and client engagement [10][16] - Investments in disruptive innovation are a key pillar of the long-term strategy, with a goal to enhance financial inclusion and sustainability [19][21] - The company aims to transition towards a more diversified business model where fee generation and client engagement are as critical as lending [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in a favorable resolution regarding the tax case with Sunnab, despite the payment of approximately 1.6 billion soles [12][53] - The macroeconomic environment is improving, with expectations of sustained engagement in the second half of the year [10][28] - The company anticipates loan growth to accelerate, particularly in retail banking, supporting a resilient net interest margin (NIM) [57] Other Important Information - The company has revised its full-year ROE guidance to around 19%, reflecting solid core performance and disciplined risk management [59] - The ongoing economic recovery is positively impacting the microfinance sector, with Mibanco's profitability rising by 16.3% [41] - Yape continues to scale, serving nearly 50 million monthly active users, and is expected to become a significant contributor to the company's revenue [17][39] Q&A Session Summary Question: What is driving the improvement in cost of risk? - Management explained that measures taken last year ensured portfolios are under risk appetite, leading to a low cost of risk. They anticipate higher yielding portfolios in the second half of the year [63][66] Question: What is the long-term vision for the physical branch network? - Management indicated that the role of branches has shifted from transactional to educational and commercial, with a significant reduction already made in the branch network [70][72] Question: What are the expectations for loan growth this year? - Management expects loan growth to be around 6.5%, primarily driven by retail segments, including mortgages and consumer credit [80][85] Question: How much can Yape contribute in the future? - Management anticipates Yape could become the second largest line of business for Credicorp, primarily due to its lending business in retail and SME segments [94][95]

Financial Data and Key Metrics Changes - The company reported a return on equity (ROE) of 20.7% for Q2 2025, reflecting strong operating performance and disciplined risk management [13][22] - Net interest income increased by 4.2%, supported by a contraction in interest expenses and a low-cost deposit structure [24][51] - The risk-adjusted net interest margin (NIM) reached a record 5.4%, aided by improved asset quality [14][52] Business Line Data and Key Metrics Changes - Universal banking and insurance and pensions posted very strong results, while microfinance continued to recover [13] - Fee income increased by 8.2%, driven by transactional activity at JAPI and BCP [25] - The innovation portfolio contributed 6.2% of risk-adjusted revenues, on track towards a 10% target for 2026 [13] Market Data and Key Metrics Changes - Peru's GDP is expected to grow by 3.2% in 2025, with domestic demand growing around 4.5% [7][27] - Inflation in Peru has remained below 2% for seven consecutive months, indicating a favorable economic environment [30] - The terms of trade have reached their highest level in 75 years, driven by elevated prices of gold, silver, and copper [27] Company Strategy and Development Direction - The company is focused on building a more agile, balanced, and forward-looking platform, emphasizing digital infrastructure and client engagement [9][16] - The strategy includes advancing digital onboarding, behavioral scoring, and embedding AI across operations to enhance efficiency and decision-making [18][20] - The company aims to transform into a more diversified business model where fee generation and client engagement are as critical as lending [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in a favorable resolution regarding the tax case with Sunnab, despite the payment of approximately 1.6 billion soles [11][54] - The company anticipates loan growth to accelerate in the second half of the year, particularly in retail banking and microfinance [56][84] - The long-term sustainable ROE guidance has been revised upwards to around 19.5%, driven by stronger expectations of loan growth dynamics [60] Other Important Information - The company is preparing for its Investor Day on October 9, where it will outline its financial services model of the future [21] - The company reported a significant gain in BCP's investment portfolio, contributing positively to the ROE [22] Q&A Session Summary Question: What is driving the improvement in cost of risk? - Management explained that measures taken last year ensured portfolios are under risk appetite, leading to a low cost of risk. They anticipate higher yielding, higher risk portfolios in the second half of the year [63][66] Question: What is the long-term vision for the physical branch network? - The company has reduced its branch network significantly and plans to continue evolving branches into more educational and commercial hubs rather than transactional centers [70][72] Question: What are the expectations for loan growth this year? - The company expects loan growth to be around 6.5%, particularly driven by retail segments, including mortgages and consumer credit [84] Question: How much can Yape contribute in the future? - Yape is expected to become the second largest line of business for the company, primarily due to its lending business in retail and SME segments [91] Question: What is the expected cost of risk for the second half of the year? - The expectation for the whole year is a cost of risk in the range of 1.8% to 2.2%, with the second half likely closer to 2% [103]

Financial Data and Key Metrics Changes - Total revenue for Q2 2025 was $25.7 million, compared to $29 million in the same quarter last year and $25.1 million in Q1 2025 [19] - Digital asset mining revenue decreased by 59% year-over-year to $6.6 million due to the April 2024 halving, higher network difficulty, and a lower active hash rate [19] - Cloud services revenue increased by 33% year-over-year to $16.6 million, driven by new customer contracts [19] - Gross profit was approximately $12.5 million, resulting in a gross margin of about 49%, up 80 basis points from the prior year [20] - Net income for the quarter was $14.9 million, or $0.07 per diluted share, compared to a net loss of $12 million in the same quarter last year [22] - Adjusted EBITDA was $27.8 million, compared to negative $3.8 million a year ago [22] - The company held $181.2 million in cash and cash equivalents as of June 30, with total liquidity of approximately $273 million [23] Business Line Data and Key Metrics Changes - Ethereum staking revenue was $400,000, down about 2% year-over-year due to higher staking rewards offset by a lower realized Ethereum price [20] - The company held approximately 121,000 ETH as of August 11, 2025, up from 3,663 ETH at the end of Q2 [11] - Active staking increased from 21,568 ETH at quarter end to approximately 105,000 ETH as of August 11, with an annualized effective yield of approximately 3.1% [12] Market Data and Key Metrics Changes - The company is focusing on building one of the largest institutional Ethereum treasury platforms in the public markets [5] - The transition to Ethereum is seen as a structural pivot, with the company aiming to generate scalable staking yield for shareholders [12] Company Strategy and Development Direction - The company aims to maximize long-term value for shareholders by focusing on Ethereum as a productive treasury asset [28] - Plans include scaling the ETH position, optimizing staking yield, and maintaining a strong liquid balance sheet [28] - The company is exploring capital market alternatives to raise further capital for purchasing additional ETH in a non-dilutive manner [30] - The separation of White Fiber is intended to provide strategic clarity and more disciplined capital allocation [7][8] Management's Comments on Operating Environment and Future Outlook - Management believes that Ethereum is becoming the financial infrastructure layer of the Internet, with major institutions building on it [26] - Regulatory clarity has improved, with recent legislation supporting the Ethereum ecosystem [27] - The company views the current market environment as favorable for Ethereum, with increasing institutional adoption [66] Other Important Information - The company is not investing in additional Bitcoin mining units and is exploring strategic alternatives for its Bitcoin mining business [15] - G&A expenses for Q2 included approximately $5.5 million in stock-based awards and consulting fees, which are expected to be nonrecurring [21] - The company remains debt-free and has signed a credit facility that transferred to White Fiber following its IPO [24] Q&A Session Summary Question: Growth in Ethereum staking among institutional investors - Management sees the growing acceptance of Ethereum staking as beneficial, noting that broader adoption validates the asset and benefits all participants [36][39] Question: Clarification on G&A expenses - Management confirmed that the increase in G&A is largely due to one-time expenses related to the IPO and acquisition, and expects future G&A to be significantly lower [48][50] Question: Support for the Ethereum ecosystem beyond ETH purchases - Management plans to increase marketing efforts for the ETH treasury strategy now that the IPO is complete, aiming to capture more mindshare in the market [60][62] Question: Regulatory framework for crypto - Management expressed optimism about the current regulatory environment, noting that recent legislation provides clarity and supports the growth of the Ethereum ecosystem [66][70] Question: Bitcoin mining strategy and fleet efficiency - Management indicated that the Bitcoin mining business is being wound down, with a focus on maintaining profitability while transitioning to a more efficient fleet [80][82]

Financial Data and Key Metrics Changes - SWK Holdings reported GAAP pretax net income of $4.6 million or $0.37 per diluted share for Q2 2025, with a net income of $3.5 million after tax expenses [8] - The GAAP book value per share was $20.23, an 11% decrease from $22.72 as of June 30, 2024, but adjusted for the $4 per share dividend, it was $24.46, reflecting a 6.8% year-over-year increase [9] - Non-GAAP adjusted net income for the finance segment was $4.6 million, indicating a stable run rate for the business going forward [5][12] Business Line Data and Key Metrics Changes - The finance receivables segment revenue decreased by $1.2 million year-over-year, primarily due to a $3.4 million decrease in interest and fees from paydowns and the sale of the majority of the royalty portfolio [8] - The pharmaceutical development segment revenue increased by $500,000 year-over-year [8] - Operating expenses for the finance receivables segment decreased significantly from $7.4 million in 2024 to $4.2 million in 2025, largely due to a reduction in provision for credit losses [10] Market Data and Key Metrics Changes - The company has returned $49 million to shareholders through a $4 per share dividend and an additional $3 million through share repurchases [4][5] - The remaining financial assets include $234 million in gross performing first lien term loans with an effective yield of 14.1% [5] Company Strategy and Development Direction - The company is focused on realizing the underlying value of its assets and ensuring shareholder benefits through asset sales and capital returns [4][5] - The management team aims to simplify the business structure and maintain a healthy loan book, indicating a disciplined approach to capital deployment [12] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the second quarter's results as a reasonable proxy for future earnings power, despite some expected noise in Q3 due to the transition services agreement with Aptar [12] - Concerns regarding regulatory changes, particularly from the FDA, were addressed, with management indicating minimal impact on their portfolio companies [22][23] Other Important Information - The company completed the sale of the majority of its royalty assets and the Mod three subsidiary, which was seen as a successful outcome for shareholders [4][6] - The company has been disciplined in capital deployment, with a focus on existing performing borrowers and cautious about new loans [30][31] Q&A Session Summary Question: What about the costs associated with the Mod three sale? - Management confirmed that all costs associated with Mod three have been transferred to Aptar, with no ongoing costs remaining on their side [15][16] Question: What is the impact of FDA changes on portfolio companies? - Management indicated that there are minimal concerns regarding FDA changes affecting their portfolio, as they do not have companies pending drug approvals [22][23] Question: How does the influx of private credit affect deal flow? - Management acknowledged the increased capital in the market but emphasized a disciplined approach to capital deployment, focusing on core deals and existing borrowers [30][31]

Financial Data and Key Metrics Changes - The company reported net revenue of BRL 15.4 billion, a 3% increase compared to the same period in 2024 [4] - EBITDA for the quarter was BRL 2.5 billion, contributing to a year-to-date total of BRL 5.3 billion, which is 11% higher than the same period last year [4] - Net income for the quarter was BRL 735 million, with a semester total of BRL 1.9 billion [4] - Free cash flow was approximately BRL 850 million, or BRL 1.3 billion when excluding the impact of the Hannon plant acquisition in China [4] - The company achieved a leverage ratio of 0.43 times LTM EBITDA, the lowest in its history [5] Business Line Data and Key Metrics Changes - In Brazil, EBITDA reached BRL 1.3 billion with a margin of 16.4%, driven by volume growth in processed products [6] - The international market showed healthy margins, with an EBITDA margin of 170.3% for the quarter [7] - The ingredients and pet segment reported EBITDA of BRL 52 million, with an 8% increase in the customer base for pet products [11] Market Data and Key Metrics Changes - The company gained a 1.4 percentage market share in processed products in the GCC, driven by the branded products category [9] - In Turkey, processed product volumes grew by 7% year-over-year, maintaining market share leadership [9] - The company expanded its export opportunities with 11 new export authorizations in 2025, contributing to price maximization [10] Company Strategy and Development Direction - The company emphasized its market diversification strategy, increasing its active customer base and strengthening its portfolio of high-quality value-added products [3][15] - The BRF Plus efficiency program continues to generate gains through continuous process improvement [15] - The company aims to expand its export options and strengthen its global presence, leveraging a robust data intelligence system for timely decision-making [17] Management's Comments on Operating Environment and Future Outlook - Management noted that the results reflect operational excellence, strategic vision, and financial discipline, even in adverse scenarios such as poultry export restrictions [2][15] - The company remains optimistic about sustainable growth, focusing on quality, safety, and integrity [19] - Management highlighted the importance of maintaining credibility and effective communication during health crises, such as avian flu [62] Other Important Information - The company reported a reduction in net debt to BRL 4.7 billion, the lowest since 2011, contributing to lower interest expenses in 2025 [14] - The company has implemented significant improvements in plant utilization and volume sold, achieving a pace of 50% higher than the historical average [12] Q&A Session Summary Question: Impact of avian flu on exports and margins - Management explained that the company has opened 198 new permits, allowing for agile reallocation of products and mitigating impacts on volume and price [24][26] - The company is optimistic about the reopening of markets, particularly in China and Europe, which are expected to happen soon [26] Question: Cost expectations with decreasing commodity prices - Management anticipates a potential 2% reduction in animal feed costs in the second half of the year due to lower grain prices [31] Question: Price resilience and future pricing strategies - Management noted that prices in Brazil increased by 11% year-over-year for processed products, with expectations for further price adjustments depending on market conditions [38] Question: Gross margin and capacity utilization - Management confirmed that there is no significant regression expected in gross margins, with ongoing improvements in operational efficiency [42][44] Question: Industry fundamentals and future profitability - Management expressed confidence in the company's resilience and competitiveness, stating that demand is expected to continue exceeding supply [51][57]